2025 FDA Lung Cancer Approvals: Precision Medicine and …
2 days ago · The year 2025 has been a pivotal period for thoracic oncology, characterized by a series of landmark approvals from the FDA that further segment the treatment landscape of non–small cell …
Clinical Trials Highlight New Treatment Approaches for Lung Cancer ...
May 16, 2025 · Enter aumolertinib, an EGFR-targeted therapy approved in China for the first-line treatment of patients with locally advanced or metastatic NSCLC that harbors an exon 19 deletion or …
New Lung Cancer Treatments Aim to Reduce Deaths in 2025 and …
Nov 15, 2024 · For people with later-stage cancers, many new treatment options have been developed. These include new chemotherapy treatments, new targeted therapies that are matched to specific …
Update 2025: Management of Non‑Small-Cell Lung Cancer - PMC
Since 2024, the non–small-cell lung cancer (NSCLC) landscape has undergone a transformative shift, driven by 11 FDA approvals. Recent advances in molecular profiling, targeted therapies, and …
What are the new drugs for NSCLC? A look at recent advancements
Oct 23, 2025 · Explore the new drugs for NSCLC, including recent FDA approvals for targeted therapies and immunotherapies. Learn about treatments like Ensartinib, Taletrectinib, and the rise of …
New promises and challenges in the treatment of advanced ... - The Lancet
Aug 6, 2024 · Targeted therapies and immunotherapies have radically improved treatment for advanced non-small-cell lung cancer (NSCLC). Tyrosine kinase inhibitors targeting oncogenic driver mutations …
Recent advances in therapeutic strategies for non-small cell lung cancer
Mar 27, 2025 · Both targeted therapy and immunotherapy have significantly improved the survival of patients with metastatic non-small-cell lung cancer (NSCLC). Additionally, recent groundbreaking …
New Drug Approvals for NSCLC: Latest Treatment Advances
Explore the latest FDA-approved treatments for NSCLC, including targeted therapies and immunotherapies, revolutionizing lung cancer care and patient outcomes.
NSCLC new treatments: A look at what is coming - labiotech.eu
Apr 30, 2025 · Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung cancer.
Personalized approaches to lung cancer treatment: A review of targeted ...
Jun 1, 2025 · Treatment options for non-small cell lung cancer (NSCLC) have significantly improved as a result of the introduction of targeted medicines. The FDA expedited approval of crizotinib, the first …